SCHEMBL29901560

SCHEMBL29901560

Clc1ccccc1C(Cl)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.53
TDO2 P48775 3/20 0.53
IDO2 Q6ZQW0 2/20 0.53
ACP3 P15309 1/20 0.50
TSHR P16473 5/20 0.48
HIF1A Q16665 2/20 0.48
LMNA P02545 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2C9 P11712 1/20 0.48
KDM4E B2RXH2 1/20 0.48
NR1I2 O75469 1/20 0.48
ABCB11 O95342 1/20 0.48
NR3C1 P04150 1/20 0.48
PGR P06401 1/20 0.48
CYP3A4 P08684 1/20 0.48
ADRA2A P08913 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
MAPT P10636 1/20 0.48
CNR1 P21554 1/20 0.48
SLC6A2 P23975 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL521541 1.00 IDO1 (0.53) IDO1TDO2IDO2ACP3TSHR
SCHEMBL11828154 0.93 TSHR (0.55) IDO1TDO2IDO2ACP3TSHR
SCHEMBL11639869 0.87 TSHR (0.47) IDO1TDO2IDO2ACP3TSHR
SCHEMBL7873189 0.86 TSHR (0.66) IDO1TDO2IDO2ACP3TSHR
SCHEMBL11617245 0.85 TSHR (0.50) IDO1TDO2IDO2ACP3TSHR
SCHEMBL7540828 0.85 IDO1 (0.56) IDO1TDO2IDO2ACP3TSHR
SCHEMBL28546831 0.83 TSHR (0.47) IDO1TDO2IDO2ACP3TSHR
SCHEMBL11644649 0.82 TSHR (0.43) IDO1TDO2IDO2ACP3TSHR
SCHEMBL365482 0.81 TSHR (0.44) ACP3TSHRHIF1ALMNACYP2C19
SCHEMBL10799696 0.79 ACP3 (0.48) ACP3TSHRLMNACYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532513-A1 CYCLIC PEPTIDES WITH ANTIBACTERIAL ACTIVITY AGAINST MULTIDRUG RESISTANT (MDR) PATHOGENS Fundación Privada Instituto De Salud Global Barcelona (ES) 2025-04-09 EP disclosed
CN-113861131-B Preparation method of cetirizine impurity C 深圳菲斯生物科技有限公司 2024-04-19 CN disclosed
CN-113861131-B Preparation method of cetirizine impurity C 深圳菲斯生物科技有限公司 2024-04-19 CN disclosed
WO-2023227771-A1 CYCLIC PEPTIDES WITH ANTIBACTERIAL ACTIVITY AGAINST MULTIDRUG RESISTANT (MDR) PATHOGENS Fundación Privada Instituto De Salud Global Barcelona (ES) 2023-11-30 WO disclosed
EP-4271480-A1 VEGF-REGULATING PEPTIDES IDP Discovery Pharma, S.L. (ES) 2023-11-08 EP disclosed
WO-2022144401-A1 VEGF-REGULATING PEPTIDES IDP DISCOVERY PHARMA, S.L. (ES) 2022-07-07 WO disclosed